EDITORIAL
Published on 06 Jul 2022
Editorial: Clinical, Molecular and Adverse Responses to B-Cell Therapies in Autoimmune Disease
doi 10.3389/fimmu.2022.962088
- 1,192 views
- Frontiers in Immunology
- B Cell Biology
- Research Topics
- Clinical, Molecular and Adverse Responses to B Cell Therapies in Autoimmune Disease
Clinical, Molecular and Adverse Responses to B Cell Therapies in Autoimmune Disease
19k
Total Downloads
63k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 02 Jun 2022
Clinical Features, Treatment, and Prognostic Factors in Neuronal Surface Antibody-Mediated Severe Autoimmune Encephalitis
doi 10.3389/fimmu.2022.890656
- 2,037 views
- 11 citations
PERSPECTIVE
Published on 19 Apr 2022
B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients
doi 10.3389/fimmu.2022.822885
- 2,397 views
- 8 citations
ORIGINAL RESEARCH
Published on 04 Apr 2022
Early B Cell and Plasma Cell Kinetics Upon Treatment Initiation Portend Flares in Systemic Lupus Erythematosus: A Post-Hoc Analysis of Three Phase III Clinical Trials of Belimumab
doi 10.3389/fimmu.2022.796508
- 4,027 views
- 8 citations
CASE REPORT
Published on 09 Feb 2022
Case Report: Rapid Desensitization to Ocrelizumab for Multiple Sclerosis Is Effective and Safe
doi 10.3389/fimmu.2022.840238
- 3,378 views
- 2 citations
SYSTEMATIC REVIEW
Published on 02 Feb 2022
Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders
doi 10.3389/fimmu.2021.788830
- 8,588 views
- 29 citations
ORIGINAL RESEARCH
Published on 12 Jan 2022
A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis
doi 10.3389/fimmu.2021.803175
- 4,682 views
- 9 citations
CASE REPORT
Published on 02 Dec 2021
Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature
doi 10.3389/fimmu.2021.777502
- 2,887 views
- 7 citations
ORIGINAL RESEARCH
Published on 29 Oct 2021
The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis
doi 10.3389/fimmu.2021.760708
- 3,803 views
- 9 citations
ORIGINAL RESEARCH
Published on 01 Oct 2021
Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study
doi 10.3389/fimmu.2021.756941
- 4,031 views
- 26 citations
ORIGINAL RESEARCH
Published on 17 Sep 2021
Peripheral B-Cell Immunophenotyping Identifies Heterogeneity in IgG4-Related Disease
doi 10.3389/fimmu.2021.747076
- 3,410 views
- 10 citations
ORIGINAL RESEARCH
Published on 14 May 2021
Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen
doi 10.3389/fimmu.2021.666022
- 2,191 views
- 7 citations
Published in
Frontiers in Immunology
- B Cell Biology
- Autoimmune and Autoinflammatory DisordersOffline
Impact
- 63kTopic views
- 42kArticle views
- 19kArticle downloads